2,549 Shares in Revvity, Inc. (NYSE:RVTY) Purchased by APG Asset Management US Inc.

APG Asset Management US Inc. bought a new position in shares of Revvity, Inc. (NYSE:RVTY - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 2,549 shares of the company's stock, valued at approximately $284,000.

Several other institutional investors also recently modified their holdings of the stock. FMR LLC raised its stake in Revvity by 40.8% during the 3rd quarter. FMR LLC now owns 155,556 shares of the company's stock valued at $19,872,000 after purchasing an additional 45,040 shares during the period. Kovitz Investment Group Partners LLC boosted its holdings in shares of Revvity by 9.6% during the third quarter. Kovitz Investment Group Partners LLC now owns 9,400 shares of the company's stock worth $1,201,000 after purchasing an additional 824 shares during the period. Orion Portfolio Solutions LLC grew its position in Revvity by 51.6% during the third quarter. Orion Portfolio Solutions LLC now owns 4,746 shares of the company's stock valued at $606,000 after purchasing an additional 1,616 shares in the last quarter. Nomura Asset Management Co. Ltd. increased its stake in Revvity by 2.0% in the 3rd quarter. Nomura Asset Management Co. Ltd. now owns 36,300 shares of the company's stock valued at $4,637,000 after buying an additional 729 shares during the period. Finally, Continuum Advisory LLC lifted its position in Revvity by 2,972.7% in the 3rd quarter. Continuum Advisory LLC now owns 338 shares of the company's stock worth $43,000 after buying an additional 327 shares in the last quarter. Institutional investors own 86.65% of the company's stock.

Analyst Ratings Changes

A number of research firms have recently weighed in on RVTY. KeyCorp upped their price target on shares of Revvity from $132.00 to $145.00 and gave the stock an "overweight" rating in a research note on Monday, February 3rd. Sanford C. Bernstein lowered Revvity from an "outperform" rating to a "market perform" rating and set a $130.00 price target for the company. in a report on Friday, January 10th. Barclays dropped their price objective on Revvity from $140.00 to $110.00 and set an "overweight" rating on the stock in a report on Thursday, April 10th. Finally, Raymond James reissued an "outperform" rating and issued a $145.00 target price (up from $140.00) on shares of Revvity in a research report on Monday, February 3rd. Four analysts have rated the stock with a hold rating, eight have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, Revvity presently has a consensus rating of "Moderate Buy" and an average price target of $133.75.

Remove Ads

Insider Activity

In other Revvity news, insider Joel S. Goldberg sold 15,170 shares of the company's stock in a transaction dated Thursday, January 30th. The shares were sold at an average price of $126.73, for a total transaction of $1,922,494.10. Following the sale, the insider now directly owns 33,400 shares of the company's stock, valued at approximately $4,232,782. This represents a 31.23 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 0.68% of the company's stock.

Revvity Stock Performance

Shares of NYSE RVTY traded down $2.02 during trading hours on Tuesday, hitting $95.60. 460,452 shares of the company's stock were exchanged, compared to its average volume of 885,481. The stock has a market capitalization of $11.49 billion, a price-to-earnings ratio of 43.26, a PEG ratio of 3.82 and a beta of 1.07. The company's 50-day moving average price is $108.62 and its 200-day moving average price is $114.90. The company has a debt-to-equity ratio of 0.41, a current ratio of 3.60 and a quick ratio of 3.03. Revvity, Inc. has a 1-year low of $89.61 and a 1-year high of $129.50.

Revvity (NYSE:RVTY - Get Free Report) last announced its quarterly earnings data on Friday, January 31st. The company reported $1.42 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.37 by $0.05. Revvity had a net margin of 9.81% and a return on equity of 7.68%. During the same period in the prior year, the business earned $1.25 EPS. On average, sell-side analysts expect that Revvity, Inc. will post 4.94 earnings per share for the current fiscal year.

Revvity Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, May 9th. Shareholders of record on Friday, April 18th will be issued a dividend of $0.07 per share. This represents a $0.28 dividend on an annualized basis and a yield of 0.29%. The ex-dividend date is Thursday, April 17th. Revvity's payout ratio is 12.67%.

Revvity Company Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.